Curated News
By: NewsRamp Editorial Staff
September 17, 2026
SS Innovations' SSi Mantra Procedures Reach 14,103, Installed Base Hits 238
TLDR
- SS Innovations SSi Mantra installations grew 42 percent to 238 systems across 12 countries as procedures surged 79 percent to 14,103.
- SS Innovations SSi Mantra uses 5 millimeter instruments for procedures like a robotic kidney operation on a 45 day old infant in India.
- SS Innovations SSi Mantra enables robotic telesurgeries and pediatric care, connecting surgeons and patients across countries to improve global health access.
- SS Innovations trained about 1,500 physicians on SSi Mantra, which performed 188 telesurgeries and may secure EU CE marking by late 2026.
Impact - Why it Matters
This news matters because it demonstrates the accelerating adoption of robotic surgery in emerging markets and beyond, potentially improving patient outcomes through minimally invasive techniques. The expansion into pediatric applications and telesurgery highlights how technology can extend specialized surgical care to underserved regions and even across borders. With regulatory milestones in the U.S. and Europe on the horizon, SS Innovations is positioning itself as a significant player in the global surgical robotics market, which could increase competition and drive innovation, ultimately benefiting patients and healthcare providers worldwide.
Summary
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is reporting continued growth in the use of its SSi Mantra surgical robotic system, with the company’s installed base and procedure count increasing as it expands into new countries and surgical applications. In an update issued September 10, the company said 238 SSi Mantra systems were installed as of September 8, up 42% from 168 at the end of 2025, following recent launches in Colombia and Sri Lanka. Procedures performed with the system reached 14,103, representing a 79% increase from 7,885 at year-end. The company also said approximately 1,500 physicians have now been trained on SSi Mantra, which has been used in a growing range of surgical specialties.
Pediatric applications continue to expand, including a robotic kidney procedure performed on a 45-day-old infant in India using 5-millimeter instruments. SS Innovations reported 188 cumulative robotic telesurgeries as of August 31, alongside long-distance procedures connecting surgeons and patients across countries. The company expects FDA review of its 510(k) submission by the end of Q1 2027 and believes EU CE marking for SSi Mantra could be obtained by the end of 2026. For more details, Read More.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, SS Innovations' SSi Mantra Procedures Reach 14,103, Installed Base Hits 238
